M3, Inc. (TYO:2413)
Japan
· Delayed Price · Currency is JPY 1,935.00
+22.50 (1.18%)
May 13, 2025, 3:30 PM JST
M3, Inc. Revenue
In the fiscal year ending March 31, 2025, M3, Inc. had annual revenue of 284.90B JPY with 19.26% growth. M3, Inc. had revenue of 79.38B in the quarter ending March 31, 2025, with 32.98% growth.
Revenue
284.90B
Revenue Growth
+19.26%
P/S Ratio
4.56
Revenue / Employee
23.55M
Employees
12,100
Market Cap
1,298.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 284.90B | 46.02B | 19.26% |
| Mar 31, 2024 | 238.88B | 8.07B | 3.49% |
| Mar 31, 2023 | 230.82B | 22.66B | 10.89% |
| Mar 31, 2022 | 208.16B | 38.96B | 23.03% |
| Mar 31, 2021 | 169.20B | 38.23B | 29.19% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |